Revisiting the Role of Mouse Mammary Tumor Virus (MMTV) in Breast Cancer Through the Lens of a Signal Peptide.
文献摘要
Mouse mammary tumor virus (MMTV) is the etiological agent of mammary carcinoma and lymphoma in mice and has been associated with human breast cancer (BC). Studies of the MMTV-encoded p14 signal peptide, derived from the envelope precursor protein, have provided insights into viral pathogenesis and its potential translational relevance in human breast cancer. While detection of viral sequences in human cancer remains controversial, identification of the p14 signal peptide has been put forward as evidence of a potential role for MMTV in human cancers, especially human breast cancer. Immunohistochemistry studies have detected p14 expression in approximately 38% of sporadic human BC specimens. p14 has cell surface localization that enables antibody-based targeting, and in murine models, p14-directed immunotherapy elicited protective antitumor responses. Finally, p14 may have a biologic role in cancer progression, localizing to the nucleolus, interacting with a variety of proteins including nucleophosmin (NPM1), and interfering with p53-associated signaling. These findings support further evaluation of p14 as a biomarker and potential therapeutic target in MMTV/HBRV-associated breast cancer. Prospective clinical validation and standardized viral detection methods are required before MMTV-positive breast cancer can be considered a distinct clinical subtype.